Researching the connection between prenatal Prozac exposure and birth defects this morning, I found an article by D.J. Goldstein et al., titled “Effects of first-trimester fluoxetine exposure on the newborn.”  This article, appearing in the May, 1997 edition of Obstetrics and Gynecology, provides important insight into the connection between gestational SSRI exposure

Recently, I found an article titled “Birth outcomes in pregnant women taking fluoxetine.”, appearing in the October 1996 edition of The New England Journal of Medicine, amounting to one of the oldest articles studying the link between gestational Prozac exposure and adverse birth outcomes.  Over the past two decades, many studies have

In 2005, T.F. Oberlander et al. published results of a study titled “Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.” in the medical journal Pediatrics, demonstrating further the risks of prenatal exposure to selective serotonin reuptake inhibitor drugs, or “SSRIs.”

The team writes “In this

In 2012, an article by B.B. McAllister et al. published in Neuroscience titled “Behavioural outcomes of perinatal maternal fluoxetine treatment.” further illustrates the risks tied to prenatal fluoxetine (Prozac) exposure, demonstrating resulting developmental issues in gestational mice.

The team writes “During and following pregnancy, women are at considerable risk of experiencing depression. For

Published in May, 2009 in Pharmacopsychiatry by a team of Australian researchers led by J. Rampono, an article titled “Placental transfer of SSRI and SNRI antidepressants and effects on the neonate.” provides further evidence that drugs such as Celexa, Lexapro, Prozac, Paxil, Zoloft, Effexor and others may cross the placenta and affect a

Over the past several decades, a number of studies have linked Celexa exposure and birth defects.  This morning, I found several more, some of which are summarized below.  For more articles demonstrating the connection between birth defects and Celexa, follow the preceding link.

In a 2013 edition of Fetal and Pediatric Pathology